“My daughter wakes up every morning wondering why she has been subjected to this cosmic joke that put her in the wrong body.” Now states are moving to ban care for kids like her.
The research base upon which medicine is built is constantly evolving. Open-mindedness and a willingness to constantly update one's knowledge are the best defenses against complacency, writes Dr. Monya De.
Creating custom hormone therapy is big business for compounding pharmacies. Regulated by state pharmacy boards and not the FDA, compounders have been known to get a pass in the face of substantial trespasses. So just how safe are these drugs?
Journalist Liz Scherer talks with Antidote blogger William Heisel about why we medicalize menopause and other life transitions in a wide-ranging conversation about media coverage of women's health.
William Heisel interviews health writer Liz Scherer about the latest coverage of the Women's Health Initiative study on hormone replacement therapy and her tips for covering women's health.
Adriane Fugh-Berman has been leading the charge against the use of drug company-sponsored ghostwriters to craft scientific articles for publication in seemingly legitimate journals. She has been a paid expert witness on behalf of plaintiffs in the litigation over hormone replacement therapy drugs, and she directs PharmedOut, a project at Georgetown University that aims to scrub industry influence from medical training.
Freelance journalist Martha Rosenberg recently made an interesting comparison between embattled drug giant Wyeth and former insurance giant AIG. The latter famously handed out massive bonuses and planned lavish company retreats at a time when the company was receiving billions in federal bailout funds.
Have you ever worked on a story where you knew that you were just one source away from a blockbuster? But you could never find that one great document that spelled out the connections or that one repentant insider willing to walk you through the corporate crime, government malfeasance or law enforcement deceit.
Thomas Sullivan founded Rockpointe Corporation, a medical education company in 1995. Since then, the company has had success creating continuing medical education materials with funding from big drug company clients and nonprofit groups such as the American Heart Association. On his blog, Sullivan and Dr.
If DesignWrite, the medical communications firm that has been ghostwriting articles on behalf of drug giant Wyeth, were an elementary school student, it would have a stack of papers heavy with gold stars.
Dr. Gloria Bachmann, the associate dean for women's health at the Robert Wood Johnson Medical School in New Brunswick, N.J., told the company it had written an "an A plus article" after it wrote a review article that Bachmann agreed to sign. The article appeared with hardly a word changed in The Journal of Reproductive Medicine.
